Core Insights - InMode Ltd. reported consolidated financial results for Q3 2025, showing a decline in revenues and net income compared to Q3 2024, attributed to cautious consumer sentiment and broader economic challenges [1][4]. Financial Performance - Total revenues for Q3 2025 were $93.2 million, down from $130.2 million in Q3 2024, which included $31.9 million from pre-order sales [3][6]. - Gross margins for Q3 2025 were 78%, compared to 82% in Q3 2024 [7]. - Net income for Q3 2025 was $21.9 million, or $0.34 per diluted share, a decrease from $51.0 million, or $0.65 per diluted share, in Q3 2024 [9]. - Non-GAAP net income for Q3 2025 was $24.5 million, or $0.38 per diluted share, compared to $55.0 million, or $0.70 per diluted share, in Q3 2024 [9]. Operational Highlights - Revenues from consumables and services increased by 26% year-over-year, totaling $19.9 million in Q3 2025 [6]. - The company maintained a total cash position of $532.3 million as of September 30, 2025, which includes cash and cash equivalents, marketable securities, and short-term bank deposits [10]. Management Commentary - CEO Moshe Mizrahy noted that the third quarter progressed in line with expectations despite ongoing global uncertainties, emphasizing the company's focus on strategic investments for long-term growth [4][5]. - CFO Yair Malca highlighted that gross margins were in line with expectations, reflecting proactive planning around tariff impacts [6]. Future Outlook - Management expects full-year revenues for 2025 to remain between $365 million and $375 million, with non-GAAP gross margins projected between 78% and 80% [15].

Company Overview - InMode Ltd. is a leading global provider of innovative medical technologies, focusing on developing, manufacturing, and marketing devices that utilize novel radio frequency (RF) technology [3] - The company aims to enable new surgical procedures and enhance existing treatments across various medical fields, including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology [3] Upcoming Events - Yair Malca, the Chief Financial Officer of InMode, will present in-person at the Baird 2025 Global Healthcare Conference in New York on September 10, 2025 [1] - The presentation will be moderated by Jeff Johnson, a Senior Research Analyst, and is scheduled for 8:30 am Eastern Time [2] - InMode will also conduct one-on-one investor meetings on the same day, with scheduling available through Baird representatives [2]

Company Overview - InMode Ltd. is a leading global provider of innovative medical technologies, focusing on developing, manufacturing, and marketing devices that utilize novel radio frequency (RF) technology [2] - The company aims to enable new surgical procedures and enhance existing treatments, offering a comprehensive line of products across various medical fields including plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology [2] Investor Conferences - InMode will participate in the 10th Annual Needham Virtual MedTech & Diagnostics Conference on August 11, 2025, with CEO Moshe Mizrahy presenting in virtual one-on-one meetings [1] - The company will also attend the Canaccord 45th Annual Global Growth Conference on August 12, 2025, featuring CFO Yair Malca in an in-person fireside chat moderated by Caitlin Cronin [1]